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INTRODUCTION
Microcins are a class of antibacterial agents produced by E. coli and its close relatives (1, 2) . Microcins are produced from ribosomally synthesized peptide precursors. The molecular weight of microcins is below 10 kDa. Some microcin precursors are heavily modified by dedicated maturation enzymes (3, 4) . One post-translationally modified microcin, microcin C (McC), is a heptapeptide with covalently attached Cterminal modified adenosine monophosphate (5, 6) . McC is produced by E. coli cells harboring plasmids carrying the mccABCDE operon (Fig. 1A) , which encodes the McC precursor, enzymes necessary for McC synthesis, and proteins that make the cell immune to produced McC. The peptide moiety of McC is encoded by 21 bp-long mccA, the shortest bacterial gene known (7, 8) . Mature McC (Fig. 1B) has a molecular weight of 1178 Da and contains a formylated N-terminal methionine, a C-terminal aspartate instead of asparagine encoded by the mccA gene, and an AMP residue attached to the α-carboxyl group of the aspartate through an N-acyl phosphoramidate linkage. The phosphate group is additionally modified by a propylamine group.
Once inside sensitive cells, McC is processed and the product of such processing (Fig. 1B) , a non-hydrolysable analog of aspartyl-adenylate -an intermediate of reaction catalyzed by aspartyl-tRNA synthetase (Fig. 1C) inhibits translation by preventing the synthesis of aminoacylated tRNA
Asp by aspartyl-tRNA synthetase (AspRS) (9) . McC processing involves deformylation of the Nterminal Met residue by peptide deformylase, followed by degradation of the peptide moiety by any one of the three broad specificity aminopeptidases, peptidases A, B, and N (10) . Whereas unprocessed McC has no effect on the aminoacylation reaction, processed McC has no effect on the growth of sensitive cells at concentrations at which intact McC efficiently inhibits growth (9) . Thus, McC is a Trojan-horse inhibitor (9, 11) : the peptide moiety is required for the entry of unprocessed McC into sensitive cells where it must be processed by peptidases to release the inhibitory aminoacyl-nucleotide part of the drug. Since AspRS of McC-producing cells is readily inhibited by processed McC, special mechanisms must exist to ensure that McC production is not deleterious to the producing cell. One such mechanism involves MccC, an export pump that specifically removes McC from the producing cell into the medium. Disruption of mccC in the context of McC-producing plasmid is toxic to the producing cell (8 ) was carried out in E. coli BL21(DE3) cells that also carried a compatible pG-KJE8 (dnaK-dnaJgrgE, groES-groEL) plasmid (Takara BIO Inc., Japan). Cells were grown at 30°C in 300 ml LB supplemented with kanamycin (50 μg/ml) and chloramphenicol (40 μg/ml). Overexpression of plasmid-borne mccE was induced by the addition of 0.1 mM IPTG to the medium. L-arabinose (4 mg/ml) and tetracycline (10 ng/ml) were also added to induce chaperone synthesis. Growth was continued in the presence of inducers for 18 h.
The resistance of cells with different plasmids to various compounds on plates was tested by placing 5 µl drops of McC (300 µM), aspartyl sulfamoyl adenosine DSA (6 mM), leucyl sulfamoyl-adenosine LSA (3 mM), and tetracycline (500 μg/ml) solutions on the surface of LB plates overlaid with 4.5 ml of soft (0.75%) LB agar seeded with 0.1-0.15 ml of induced overnight (OD 600 ~2.5) bacterial cultures to be tested. Soft agar used for overlay contained 0.1 mM IPTG.
Albomycin sensitivity was tested in liquid cultures using E. coli BL21(DE3) harboring pET28 vector-based plasmids expressing MccE, wild-type or mutant MccE CTD , or cells carrying the pET28 vector alone. Exponentially growing uninduced cultures were diluted with LB medium to OD=0.1, and 0.1 ug/ml of albomycin was added (zero time point). Since addition of IPTG was found to affect the growth of some cells, IPTG induction was not used in this experiment. Cell growth was monitored in the presence of 0.1 µg/ml almomycin. Cultures that did not receive albomycin served as controls.
To purify recombinant MccE or its domains, cells were harvested by centrifugation and resuspended in 6 ml of buffer A (20 mM phosphate buffer, pH 7.2, 0.05 M NaCl) containing 1 mg/ml lysozyme. After 1h incubation on ice, cells were disrupted by sonication and cell debris was removed by centrifugation. The supernatant was loaded on a 1 ml chelating HiTrap column (GE Healthcare) charged with Ni 2+ according to the manufacturer instructions. The column was washed with buffer A containing 40 mM imidazole and bound protein was eluted with the same buffer containing 250 mM imidazole. The resulting proteins were ~95% pure as judged by Coumassie staining of SDS gels. Recombinant proteins were concentrated by ultrafiltration, glycerol was added to a final concentration 50% and samples were stored at −20°C until further use.
Acetyltransferase activity assays
Acetyltransferase activity was measured using a method described by Bode et 
Chemical characterization of acetylation products
Liquid chromatography coupled with mass spectrometry was used to analyze the acetylation reaction products. The samples were redissolved in 20 µl methanol:water (1:1) and 100 nl of this mixture was injected directly onto the HPLC system (CapLC, Waters, Milford, MA). The separation was performed on a hydrophilic interaction column (Grace Alltima HP Hilic, 150 mm x 300 µm, Deerfield, IL) thermostated at 40°C. Acetonitrile (HPLC gradient grade, Fisher Scientific, Loughborough, UK) was used as organic phase and ammonium formate 25 mM (pH 6.3) as aqueous phase. Flow rate was 5 µl/min, the gradient started at 86% acetonitrile and the components were eluted by increasing the aqueous phase by 4%/min for 15 minutes. Electrospray mass spectra were recorded in negative ionization mode on an orthogonal acceleration quadrupole time-of-flight mass spectrometer (Q-Tof 2, Micromass, Manchester, UK).
Electrospray capillary voltage was set to -2850 V. Mass spectra (scan time 0.9 sec, inter scan delay 0.1 sec, m/z range 200-550) and fragment ion spectra (scan time 1.9 sec, inter scan delay 0.1 sec, m/z range 50-550) were recorded alternatingly. Argon was used as collision gas and the collision energy was set to 10 eV, 20 eV and 15 eV for DSA, LSA, and ESA, respectively. The collision cell voltages were optimized based on the fragmentation pattern of the compounds in such way that the fragments as well as the precursor ion could be observed simultaneously.
Preparation of E. coli S30 cell extracts E. coli cells were grown to OD 600 of ~0.8 in LB medium. Cells were collected by centrifugation, and washed with 40 mM Tris-HCl, pH 7.6, 10 mM Mg(OAc) 2 , 50 mM KOAc, 0.1 mM EDTA, 1 mM DTT. The cell pellet was resuspended in an equal volume of the same buffer and disrupted using French press (pressure 1000 bar). The lysate was next centrifuged at 30.000 g for 30 min. Then supernatant was aliquoted and either directly used in tRNA aminoacylation reactions or stored at -80 o C until further use.
tRNA aminoacylation reaction
Aminoacylation reaction was carried out according to the method described in Metlitskaya et al., 2006 with some modifications. To 1 μl of solution containing an inhibitor being tested, 3 μl of E. coli S30 extract was added. Next, 16 μl of aminoacylation mixture (30 mM Tris-HCl, pH 8.0, 1 mM DTT, 5 g/l bulk E. coli tRNA, 3 mM ATP, 30 mM KCl, 8 mM MgCl 2 , and 40 μM of desired labeled amino acid) was added and reactions were incubated at room temperature for 5 min. The reactions were terminated by the addition of cold 10% TCA and precipitated reaction products were collected on Whatman 3MM paper filters.
After thorough washing with cold 10% TCA, the filters were washed twice with acetone and dried on a heating plate. Following the addition of scintillation liquid, the amount of radioactivity was determined in a scintillation counter.
RESULTS
Extracts of cells producing McC contain an activity that relieves McC inhibition
In the experiment shown in Fig. 2A , McC was added to S30 extracts prepared from E. coli cells with or without the McCproducing plasmid pUHAB (12) and, after a 50-min incubation, which is a sufficient time for McC processing by endogenous peptidases (10), AspRS activity was measured. As can be seen, the addition of McC to extracts of cells that did not contain pUHAB led to complete and irreversible inhibition of tRNA Asp aminoacylation by AspRS. In contrast, the inhibition of AspRS activity in extracts of cells carrying pUHAB was incomplete after 50 minutes and the activity gradually recovered upon longer incubations. In the experiment shown in Fig.  2B , McC was incubated with S30 extract prepared from cells lacking pUHAB to allow complete processing, combined with fresh extracts prepared from cells with or without pUHAB, and AspRS activity was monitored over time. As can be seen, in extracts without pUHAB, AspRS activity remained constant and low at all time points tested. In contrast, in extracts containing pUHAB, the AspRS activity gradually recovered with time. The result thus indicates that in extracts of McC-producing cells there exists an activity that detoxifies processed McC. 18) . The correction of the sequence led to an ambiguity in the assignment of the mccE start codon, which was originally proposed to begin with an ATG (7, 8) (Fig.  3) . In the corrected sequence, this codon is out of frame with the mccE ORF. Cursino et al., 2006 proposed that in their sequence, a nearby downstream in-frame GTG could serve as a start codon (Fig. 3) . Šmajs et al. (18) proposed that translation of MccE is initiated much more upstream, from an ATG codon overlapping with mccD (Fig. 3) . For our purposes, it was essential to know the exact starting point of the mccE gene. To this end, several amber mutations were introduced in the "non-coding" sequence between mccD and the previously annotated downstream mccE start sites (MccE codons substituted for amber codons are indicated by asterisks in Fig. 3 (Fig. 4A) . In contrast, cells harboring the pET vector remained fully sensitive (Fig. 4A) (Fig. 1D) 
Chemical characterization of MccE acetylation products
The products of MccE-catalyzed in vitro acetylation of DSA, LSA, and ESA were separated by hydrophilic interaction liquid chromatography (HILIC), a convenient method for analysis of polar compounds not easily retained on reversed phase columns. During HILIC, the more apolar acetylated reaction products should elute earlier than the starting compounds. Indeed, the presence of peaks eluting earlier than the starting DSA, LSA, and ESA was detected during HILIC analysis of the products of MccE-catalyzed acetylation reactions. The starting compounds and the material from the earlier eluting peaks were analyzed by mass spectrometry. Negative ionization mode was used because the sulfamoyl moiety has acidic properties and can be deprotonated. No traces for the original unacetylated compounds (m/z values 460, 458, and 474 for DSA, LSA, and ESA, correspondingly) were found in extracted ion chromatograms of the products of acetylation reactions (Fig. 6, left To determine the site of acetylation, the reaction products were characterized by acquisition of fragment ion spectra. Cleavage of the sulfonamide group yields an abundant ion with m/z of 345, which is observed for each of the native (not shown) and acetylated (Fig. 6, right panels) compounds. The common fragment corresponds to the nucleotide moiety of AaSAs. Therefore, it is the aminoacyl moiety that undergoes acetylation. Since either aspartyl, glutamyl, or leucyl moieties are acetylated, the acetyl group must be located on the α-amino group.
Acetylated AaSAs do not inhibit cognate tRNA synthetases
To reconcile the results of the in vitro acetylation assays with in vivo data, one has to postulate that acetylated AaSAs lose the ability to inhibit cognate tRNA synthetases. To check this idea, aliquots of acetylation reactions containing AaSAs were combined with E. coli S30 extracts and tRNA Asp , tRNA Leu , and tRNA Glu aminoacylation reactions were performed (Fig. 7) . In agreement with our expectations, aminoacylation reactions conducted in the presence of AaSAs acetylated by MccE CTD proceeded as efficiently as in the absence of inhibitors. In contrast, reactions conducted in the presence of AaSAs that had been preincubated with MccE NTD and acetyl-CoA or acetyl-CoA alone were fully inhibited. Thus, upon acetylation by MccE CTD , AaSAs lose the ability to inhibit aminoacylation of cognate tRNAs.
MccE acetyltransferase makes cells resistant to albomycin when overexpressed Albomycin is a Trojan-horse inhibitor that consists of a ferrichrome-like siderophore coupled to a serine that is attached to a thioxylofuranosyl pyrymidine (21) . Upon entering cells through the FhuA ferrichrome transporter, albomycin is processed by aminopeptidases with the release of a nonhydrolizable seryl-thioxylofuranosyl pyrimidine (22) that inhibits SerRS (23). As can be seen from Fig. 8 Fig. 1 ). The MccE acetyltranferease domain is more distantly related to other Rim proteins (RimI, and RimJ, each specifically acetylating a dedicated ribosomal protein), bacterial GNAT enzymes, and eukaryotic homologs ( Supplementary Fig. 1 
